Initial Pseudomonas aeruginosa infection in patients with cystic fibrosis: characteristics of eradicated and persistent isolates

被引:32
作者
Tramper-Stranders, G. A. [1 ]
van der Ent, C. K. [1 ]
Molin, S. [2 ]
Yang, L. [2 ]
Hansen, S. K. [2 ]
Rau, M. H. [2 ]
Ciofu, O. [3 ]
Johansen, H. K. [4 ,5 ]
Wolfs, T. F. W. [6 ]
机构
[1] Wilhelmina Childrens Hosp, Cyst Fibrosis Ctr, Univ Med Ctr Utrecht, Dept Paediat Resp Med, NL-3508 AB Utrecht, Netherlands
[2] Tech Univ Denmark, Infect Microbiol Grp, Ctr Syst Biol, DK-2800 Lyngby, Denmark
[3] Univ Copenhagen, Inst Int Hlth Immunol & Microbiol, Copenhagen, Denmark
[4] Rigshosp, Dept Clin Microbiol, DK-2100 Copenhagen, Denmark
[5] Rigshosp, Danish CF Ctr, DK-2100 Copenhagen, Denmark
[6] Wilhelmina Childrens Hosp, Dept Paediat Infect Dis, Univ Med Ctr Utrecht, NL-3508 AB Utrecht, Netherlands
关键词
Chronic infection; cystic fibrosis; genotyping; Pseudomonas aeruginosa; virulence; III SECRETION; PULMONARY INFECTIONS; GENETIC ADAPTATION; DCTA GENE; COLONIZATION; VIRULENCE; STRAINS; MICROEVOLUTION; INACTIVATION; PATHOGEN;
D O I
10.1111/j.1469-0691.2011.03627.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Clin Microbiol Infect 2012; 18: 567574 Abstract Despite intensive eradication therapy, some CF patients with early Pseudomonas aeruginosa infection rapidly develop a chronic infection. To elucidate factors associated with this persistence, bacterial characteristics of early P. aeruginosa isolates were analysed that were either eradicated rapidly or persisted despite multiple antimicrobial treatments. Eighty-six early infection episodes were studied. First P. aeruginosa isolates from patients with eradication (36) or persistent infection (16) were included; isolates from patients with intermittent infection (34) were omitted from the study. Virulence assays, antimicrobial resistance, cytotoxicity and mutation frequencies were analysed in vitro. P. aeruginosa was genotyped by SNP-array. Transcriptomic profiles of two eradicated and two persistent strains were compared. Nineteen per cent of patients developed persistent infection; 42% achieved eradication. Secretion of virulence factors and mutation frequencies were highly variable among both eradicated and persistent isolates and were not different between the groups. Cytotoxicity was present in 57% of eradicated vs. 100% of persistent isolates (p <0.01). None of the isolates were resistant to antibiotics. The isolates were genotypically highly diverse. Multivariate analysis showed that in vitro determined bacterial characteristics could not predict persistence after first P. aeruginosa infection. Preliminary transcriptomic data showed increased expression of some genes related to a metabolic pathway. The early onset of chronic infection was not associated with (in vitro determined) bacterial characteristics only. Although the persistent isolates were more often cytotoxic, for the individual patient it was not possible to predict the risk of persistence based on bacterial characteristics. Unknown factors such as host-pathogen and pathogen-pathogen interactions should be further explored.
引用
收藏
页码:567 / 574
页数:8
相关论文
共 50 条
  • [41] The Costs of Treatment of Early and Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis Patients
    Braccini, G.
    Festini, F.
    Boni, V.
    Neri, A. S.
    Galici, V.
    Campana, S.
    Zavataro, L.
    Trevisan, F.
    Braggion, C.
    Taccetti, G.
    JOURNAL OF CHEMOTHERAPY, 2009, 21 (02) : 188 - 192
  • [42] Novel conjugate vaccine for the prevention of pseudomonas aeruginosa infection in cystic fibrosis patients
    Matson, Kelly L.
    Bratberg, Jeffrey P.
    DRUG DEVELOPMENT RESEARCH, 2007, 68 (08) : 512 - 521
  • [43] Survey of Pseudomonas aeruginosa genotypes in colonised cystic fibrosis patients
    Van daele, S.
    Vaneechoutte, M.
    De Boeck, K.
    Knoop, C.
    Malfroot, A.
    Lebecque, P.
    Leclercq-Foucart, J.
    Van Schil, L.
    Desager, K.
    De Baets, F.
    EUROPEAN RESPIRATORY JOURNAL, 2006, 28 (04) : 740 - 747
  • [44] Pseudomonas Aeruginosa: Genetic Adaptation, A Strategy for its Persistence in Cystic Fibrosis
    Rosales-Reyes, Roberto
    Vargas-Roldan, Silvia Yalid
    Lezana-Fernandez, Jose Luis
    Santos-Preciado, Jose Ignacio
    ARCHIVES OF MEDICAL RESEARCH, 2021, 52 (04) : 357 - 361
  • [45] Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients
    Smith, Eric E.
    Buckley, Danielle G.
    Wu, Zaining
    Saenphimmachak, Channakhone
    Hoffman, Lucas R.
    D'Argenio, David A.
    Miller, Samuel I.
    Ramsey, Bonnie W.
    Speert, David P.
    Moskowitz, Samuel M.
    Burns, Jane L.
    Kaul, Rajinder
    Olson, Maynard V.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (22) : 8487 - 8492
  • [46] Nebulized liposomal amikacin for the treatment of Pseudomonas aeruginosa infection in cystic fibrosis patients
    Ehsan, Zarmina
    Wetzel, Jacqueline Denise
    Clancy, John P.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (05) : 743 - 749
  • [47] Iron acquisition by Pseudomonas aeruginosa in the lungs of patients with cystic fibrosis
    Lamont, Iain L.
    Konings, Anna F.
    Reid, David W.
    BIOMETALS, 2009, 22 (01) : 53 - 60
  • [48] Iron acquisition by Pseudomonas aeruginosa in the lungs of patients with cystic fibrosis
    Iain L. Lamont
    Anna F. Konings
    David W. Reid
    BioMetals, 2009, 22 : 53 - 60
  • [49] Comparative genomics and biological characterization of sequential Pseudomonas aeruginosa isolates from persistent airways infection
    Bianconi, Irene
    Jeukens, Julie
    Freschi, Luca
    Alcala-Franco, Beatriz
    Facchini, Marcella
    Boyle, Brian
    Molinaro, Antonio
    Kukavica-Ibrulj, Irena
    Tuemmler, Burkhard
    Levesque, Roger C.
    Bragonzi, Alessandra
    BMC GENOMICS, 2015, 16
  • [50] Mucin adhesion of serial cystic fibrosis airways Pseudomonas aeruginosa isolates
    Herrmann, Christian
    Lingner, Meike
    Herrmann, Susanne
    Brockhausen, Inka
    Tuemmler, Burkhard
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14